Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krista Y Chen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Oncologist|March 26, 2025
Response to: Local social vulnerability as a predictor for cancer-related mortality among US countiesKrista Y Chen, Amanda L Blackford, Ramy Sedhom, et al.
Plos One|July 11, 2024
Patient perspectives on cancer care during COVID-19: A qualitative studyKrista Y Chen, Olivia Stanford, Jennifer A Wenzel, et al.
The Oncologist|June 19, 2023
Local Social Vulnerability as a Predictor for Cancer-Related Mortality Among US CountiesKrista Y Chen, Amanda L Blackford, Ramy Sedhom, et al.
Cancer Medicine|March 10, 2025
Transparency and Representation in Clinical Research Utilizing Artificial Intelligence in Oncology: A Scoping ReviewAnjali J D'Amiano, Tia Cheunkarndee, Chinenye Azoba, et al.
Clinical Trials (London, England)|April 28, 2022
Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysisKrista Y Chen, Erin M Borglund, Emma Charlotte Postema, et al.
JAMA|July 30, 2025
Demographic Data Supporting FDA Authorization of AI Devices for Alzheimer Disease and Related DementiasKrista Y Chen, Joseph S Ross, Adam B Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthKrista Y Chen, Joseph S Ross, Adam B Cohen, et al.
JAMA Pediatrics|October 10, 2022
Trends in Dispensing of Controlled Medications for US Adolescents and Young Adults, 2008 to 2019Michael S Toce, Kenneth A Michelson, Krista Y Chen, et al.
JAMA Network Open|July 31, 2025
Nationwide Analysis of Legal Barriers to Cancer CareKrista Y Chen, Amanda L Blackford, Monica F Bryant, et al.
Cancers|November 11, 2022
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint InhibitorsKrista Y Chen, Aleksandra Popovic, David Hsiehchen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Oncologist|March 26, 2025
Response to: Local social vulnerability as a predictor for cancer-related mortality among US countiesKrista Y Chen, Amanda L Blackford, Ramy Sedhom, et al.
Plos One|July 11, 2024
Patient perspectives on cancer care during COVID-19: A qualitative studyKrista Y Chen, Olivia Stanford, Jennifer A Wenzel, et al.
The Oncologist|June 19, 2023
Local Social Vulnerability as a Predictor for Cancer-Related Mortality Among US CountiesKrista Y Chen, Amanda L Blackford, Ramy Sedhom, et al.
Cancer Medicine|March 10, 2025
Transparency and Representation in Clinical Research Utilizing Artificial Intelligence in Oncology: A Scoping ReviewAnjali J D'Amiano, Tia Cheunkarndee, Chinenye Azoba, et al.
Clinical Trials (London, England)|April 28, 2022
Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysisKrista Y Chen, Erin M Borglund, Emma Charlotte Postema, et al.
JAMA|July 30, 2025
Demographic Data Supporting FDA Authorization of AI Devices for Alzheimer Disease and Related DementiasKrista Y Chen, Joseph S Ross, Adam B Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthKrista Y Chen, Joseph S Ross, Adam B Cohen, et al.
JAMA Pediatrics|October 10, 2022
Trends in Dispensing of Controlled Medications for US Adolescents and Young Adults, 2008 to 2019Michael S Toce, Kenneth A Michelson, Krista Y Chen, et al.
JAMA Network Open|July 31, 2025
Nationwide Analysis of Legal Barriers to Cancer CareKrista Y Chen, Amanda L Blackford, Monica F Bryant, et al.
Cancers|November 11, 2022
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint InhibitorsKrista Y Chen, Aleksandra Popovic, David Hsiehchen, et al.
Pageof 2